Spots Global Cancer Trial Database for DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer
Official Title: DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer
Study ID: NCT00400426
Interventions
Study Description
Brief Summary: Palliative radiotherapy for head and neck cancer is widely used but the effect and side effects are largely unknown. We will study the effect of short hypofractionated palliative radiotherapy (20 Gy in 4 fractions) on symptom intensity and -frequency as weel as side effects
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Department of Oncology, Aarhus, , Denmark
Contact Details
Name: Kenneth Jensen, MD
Affiliation: DAHANCA (Danish Head and Neck Cancer Group)
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
